[go: up one dir, main page]

AUPP751198A0 - Purification of A1-proteinase inhibitor - Google Patents

Purification of A1-proteinase inhibitor

Info

Publication number
AUPP751198A0
AUPP751198A0 AUPP7511A AUPP751198A AUPP751198A0 AU PP751198 A0 AUPP751198 A0 AU PP751198A0 AU PP7511 A AUPP7511 A AU PP7511A AU PP751198 A AUPP751198 A AU PP751198A AU PP751198 A0 AUPP751198 A0 AU PP751198A0
Authority
AU
Australia
Prior art keywords
purification
proteinase inhibitor
proteinase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP7511A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd filed Critical CSL Ltd
Priority to AUPP7511A priority Critical patent/AUPP751198A0/en
Publication of AUPP751198A0 publication Critical patent/AUPP751198A0/en
Priority to PCT/AU1999/001082 priority patent/WO2000034453A1/en
Priority to AU17623/00A priority patent/AU1762300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
AUPP7511A 1998-12-04 1998-12-04 Purification of A1-proteinase inhibitor Abandoned AUPP751198A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP7511A AUPP751198A0 (en) 1998-12-04 1998-12-04 Purification of A1-proteinase inhibitor
PCT/AU1999/001082 WO2000034453A1 (en) 1998-12-04 1999-12-06 PURIFICATION OF α1-PROTEINASE INHIBITOR
AU17623/00A AU1762300A (en) 1998-12-04 1999-12-06 Purification of alpha1-proteinase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP7511A AUPP751198A0 (en) 1998-12-04 1998-12-04 Purification of A1-proteinase inhibitor

Publications (1)

Publication Number Publication Date
AUPP751198A0 true AUPP751198A0 (en) 1999-01-07

Family

ID=3811721

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP7511A Abandoned AUPP751198A0 (en) 1998-12-04 1998-12-04 Purification of A1-proteinase inhibitor

Country Status (2)

Country Link
AU (1) AUPP751198A0 (en)
WO (1) WO2000034453A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0212952A (en) 2001-10-05 2004-10-13 Basf Ag Processes for cross-linking and surface cross-linking of starting polymers, matter composition, polymer, and, uses of polymers and a matter composition
AU2021249040A1 (en) * 2020-03-31 2022-09-15 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation from C-1 inhibitor depleted plasma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610633B1 (en) * 1987-02-05 1992-09-18 Lille Transfusion Sanguine PROCESS FOR OBTAINING A 1-ANTITRYPSIN CONCENTRATE FROM HUMAN PLASMA AND THE USE THEREOF AS A MEDICAMENT
JPH0551396A (en) * 1991-08-20 1993-03-02 Asahi Chem Ind Co Ltd Method for separating saccharified albumin
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5561108A (en) * 1994-07-29 1996-10-01 Bayer Corporation Preparation of α1 -antichymotrypsin

Also Published As

Publication number Publication date
WO2000034453A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
AU3140695A (en) 1h-indole-1-functional spla2 inhibitors
AU5100599A (en) Egf-genistein for prevention of restenosis
AU1271297A (en) Inhibitor of ceramidase
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
AU1536799A (en) Bishydroxyureas as inhibitors of the 5-lipoxygenase
IL141433A0 (en) Crystalline forms of eto2c-ch2- (r) cgl-aze-pab-oh
PL329153A1 (en) Derivatives of pyrrolopyrolone as inhibitors of neutropil elastase
AU2361897A (en) Corrosion inhibitor
EP1049716A4 (en) Purification of fibrinogen
AU2558797A (en) Purification of nitrile
AU2277597A (en) New inhibitors of sh2-mediated processes
WO2000001393A8 (en) OLIGONUCLEOTIDE INHIBITORS OF bcl-xL
AU1287100A (en) Peptide inhibitor of browman-birk type
AU5673099A (en) Inhibitors of amyloid formation
AU2373600A (en) Novel spla2 inhibitors
AU6422798A (en) Stabilized urease inhibitor
AU8005100A (en) Inhibitors of neuraminidases
AUPP910699A0 (en) Inhibitor of lipoxygenase pathways
AUPP385598A0 (en) Purification of antibodies
AU5126298A (en) Inhibition of crib-biting
AUPP751198A0 (en) Purification of A1-proteinase inhibitor
AU3959499A (en) Process of purifying angiogenesis inhibitors
AU5622599A (en) Use of 5-amino-pyrazol-derivatives for combating micro-organisms
AU2629599A (en) Purification of tramadol
AU2017800A (en) Purification of water

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 1762300

Country of ref document: AU